vestibular neuronitis: Idiopathic inflammation of the vestibular nerve, characterized clinically by the acute or subacute onset of vertigo; nausea; and imbalance. The cochlear nerve is typically spared and hearing loss and tinnitus do not usually occur. Symptoms usually resolve over a period of days to weeks. (Adams et al., Principles of Neurology, 6th ed, p304)
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4020 |
4. Check minimum number of eventsNone |
4020 |
5. Include endpointsNone |
4020 |
6. Filter based on genotype QC (FinnGen only) |
3658 |
Control definitions (FinnGen only)
- Control exclude
- H8_INNER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H81
- Name in latin
- Neuronitis vestibularis
Similar endpoints
↥List of similar endpoints to
Vestibular neuronitis
based on the number of shared cases.
Similar with more cases:
- Disorders of vestibular function (Vertigo)
- Diseases of inner ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 24109 | 13022 | 10994 |
| Only index persons | 22996 | 12504 | 10492 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.34 | 0.37 | 0.31 |
| Only index persons | 0.43 | 0.46 | 0.40 |
| Median age at first event (years) | |||
| Whole population | 55.00 | 55.56 | 54.40 |
| Only index persons | 54.48 | 54.96 | 53.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3658 | 2086 | 1572 |
| Unadjusted period prevalence (%) | 0.73 | 0.74 | 0.72 |
| Median age at first event (years) | 55.96 | 54.96 | 57.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3777
- Matched controls
- 37770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R42
ICD-10 Finland
Dizziness and giddiness
10.0
307.7
2326
5216
DFF59
NOMESCO Finland
Other assessment of balance
30.5
307.7
230
80
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
9.1
307.7
876
1219
3861A
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo
+∞
307.7
320
*
H81.3
ICD-10 Finland
Other peripheral vertigo
37.3
307.7
455
138
H81.2
ICD-10 Finland
Vestibular neuronitis
17310.4
307.7
3474
25
H81.0
ICD-10 Finland
Ménière disease
35.2
302.3
191
57
H81.9
ICD-10 Finland
Disorder of vestibular function, unspecified
26.0
222.7
155
62
AA1AD
NOMESCO Finland
CT of head and brain
2.9
215.9
1615
7700
N07CA01
ATC
betahistine; oral
5.0
204.6
487
1094
DFF00
NOMESCO Finland
Pure tone audiometry
3.5
160.3
656
2168
H02AB04
ATC
methylprednisolone; systemic
3.0
155.3
845
3303
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
36.4
142.6
89
25
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.7
117.0
755
3187
N17
ICPC
Vertigo/dizziness
2.8
116.3
694
2813
DFF50
NOMESCO Finland
Electronystagmography
50.7
86.5
50
10
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.4
61.1
450
1983
H02AB06
ATC
prednisolone; systemic
1.7
57.6
1907
14018
H81.4
ICD-10 Finland
Vertigo of central origin
12.1
54.9
55
46
UDC00
NOMESCO Finland
Ear microscopy
2.6
53.8
338
1379
N05AB04
ATC
prochlorperazine; systemic, rectal
4.5
47.2
117
267
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
6.3
45.9
78
127
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
5.6
44.4
84
152
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
42.3
889
5654
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.0
39.4
182
631
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
10.1
37.2
42
42
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
3.5
35.7
126
371
PA6AD
NOMESCO Finland
CT of neck arteries
2.7
31.0
177
687
A02BC02
ATC
pantoprazole; systemic
1.5
30.8
2580
22099
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
28.6
338
1781
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.5
28.5
180
734
R51.80
ICD-10 Finland
Headache
1.7
28.0
565
3512
R11
ICD-10 Finland
Nausea and vomiting
2.0
26.8
331
1770
G44.2
ICD-10 Finland
Tension-type headache
1.7
25.2
490
3010
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.8
24.7
371
2112
H82
ICPC
Vertiginous syndrome
3.6
24.5
82
234
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
24.4
796
5555
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
23.8
2281
19517
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
22.9
1760
14447
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
4.2
22.4
59
142
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.6
21.9
619
4168
M79.6
ICD-10 Finland
Pain in limb
1.4
21.1
1578
12831
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
20.3
1247
9785
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
105.6
19.6
21
*
H81.8
ICD-10 Finland
Other disorders of vestibular function
21.7
19.5
28
13
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.3
18.9
147
659
M03BX02
ATC
tizanidine; oral
1.4
18.7
2187
18959
H80.9
ICD-10 Finland
Otosclerosis, unspecified
70.2
18.7
21
*
C08CA01
ATC
amlodipine; oral
1.4
17.9
1386
11243
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
17.8
997
7664
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.3
16.3
122
538
SPAT1310
SPAT
Counselling related to known health issue
1.4
15.8
1049
8265
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.0
15.4
69
236
C08CA13
ATC
lercanidipine; oral
1.5
15.3
520
3629
A98
ICPC
Health maint/preventive medicine
1.9
15.2
3608
34672
SPAT1263
SPAT
Sampling
1.3
14.8
1373
11355
N02BE01
ATC
paracetamol; systemic, rectal
1.5
14.6
3275
30785
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.7
14.5
77
289
R01AD09
ATC
mometasone; nasal
1.3
14.5
1509
12672
H93.1
ICD-10 Finland
Tinnitus
1.8
14.5
236
1373
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
14.4
607
4416
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
14.3
774
5882
SPAT1043
SPAT
Audiometry
1.6
14.2
335
2153
J01FA10
ATC
azithromycin; systemic
1.3
14.1
1903
16534
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
14.0
1379
11479
J01DB01
ATC
cefalexin; oral
1.4
13.7
2948
27280
M25.5
ICD-10 Finland
Pain in joint
1.3
13.6
1128
9152
UJF32
NOMESCO Finland
Coloscopy
1.4
13.6
890
6972
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
13.4
240
1435
C09CA06
ATC
candesartan; oral
1.4
13.4
834
6479
R05
ICPC
Cough
1.4
13.3
836
6505
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
13.2
991
7917
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
13.2
267
1649
A02BC05
ATC
esomeprazole; systemic
1.3
13.2
1391
11659
G43.9
ICD-10 Finland
Migraine, unspecified
1.9
13.2
180
994
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
13.1
888
6988
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.4
13.0
90
385
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
12.6
2473
22412
R03AC02
ATC
salbutamol; inhalant
1.3
12.5
1850
16170
J01AA02
ATC
doxycycline; systemic
1.3
12.4
2762
25434
R53
ICD-10 Finland
Malaise and fatigue
1.4
12.3
821
6433
M79.1
ICD-10 Finland
Myalgia
1.5
12.3
487
3496
C09CA01
ATC
losartan; oral
1.3
12.2
893
7098
R06.0
ICD-10 Finland
Dyspnoea
1.3
12.0
915
7311
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
2.7
11.9
61
226
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
11.8
270
1720
M01AH05
ATC
etoricoxib; oral
1.3
11.7
2166
19385
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
11.7
229
1403
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
11.6
201
1191
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
11.5
992
8062
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
11.4
1560
13448
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
4.1
11.4
31
77
J01MA02
ATC
ciprofloxacin; systemic
1.3
11.3
1288
10853
DC1AD
NOMESCO Finland
Temporalbone CT
3.4
11.2
40
120
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
11.2
1491
12803
A04AA01
ATC
ondansetron; systemic, rectal
1.6
11.2
282
1841
H02
ICPC
Hearing complaint
1.4
11.1
482
3512
J01FA09
ATC
clarithromycin; systemic
1.3
11.1
1000
8164
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.0
1474
12654
A02BC01
ATC
omeprazole; systemic
1.3
11.0
874
7013
TAB00
NOMESCO Finland
Lumbar puncture
1.9
10.9
144
787
Z01.2
ICD-10 Finland
Dental examination
1.3
10.9
1520
13110
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
10.8
789
6251
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.8
1455
12489
N02AX02
ATC
tramadol; systemic, rectal
1.3
10.8
1452
12463
M01AE01
ATC
ibuprofen; systemic, rectal
1.4
10.7
3223
30533
L08
ICPC
Shoulder symptom/complaint
1.3
10.4
787
6264
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
10.4
927
7549
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.2
10.3
27
65
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
10.3
755
5982
SPAT1097
SPAT
Recording of ECG
1.4
10.3
463
3396
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
10.3
444
3233
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
10.2
463
3401
L01
ICPC
Neck symptom/complaint
1.4
10.2
519
3889
C10AA05
ATC
atorvastatin; oral
1.3
10.2
1462
12625
R74
ICPC
Upper respiratory infection acute
1.3
10.1
983
8091
G04CA01
ATC
alfuzosin; oral
1.5
10.1
383
2723
H29
ICPC
Ear symptom/complaint other
1.4
10.1
389
2775
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.6
10.1
244
1578
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
10.0
554
4206
M54.5
ICD-10 Finland
Low back pain
1.3
10.0
1206
10195
C07AB07
ATC
bisoprolol; oral
1.2
9.9
1652
14489
N02BF01
ATC
gabapentin; oral
1.5
9.9
348
2436
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
9.9
1411
12159
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
9.8
393
2824
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
9.6
594
4587
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
9.6
1182
10007
J02AC01
ATC
fluconazole; systemic
1.3
9.6
1245
10606
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
9.4
582
4493
N03AX12
ATC
[U] gabapentin; oral
1.4
9.4
519
3937
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
9.4
282
1913
L03
ICPC
Low back symptom/complaint
1.3
9.3
952
7875
H81
ICD-10 Finland
Disorders of vestibular function
10.7
9.3
17
16
A11
ICPC
Chest pain NOS
1.5
9.3
280
1902
N30.0
ICD-10 Finland
Acute cystitis
1.4
9.2
538
4115
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
2.7
9.2
49
186
R01AD12
ATC
fluticasone furoate; nasal
1.3
9.1
969
8048
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
9.1
473
3551
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.2
9.1
1835
16379
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.0
470
3530
DDA00
NOMESCO Finland
Stapedotomy
36.8
9.0
11
*
J01CA04
ATC
amoxicillin; systemic
1.3
9.0
2827
26472
SAA02
NOMESCO Finland
Basic examination of mouth
1.2
8.9
2211
20149
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
8.9
1498
13110
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
2.1
8.8
81
391
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.3
8.8
742
5978
G47.3
ICD-10 Finland
Sleep apnoea
1.3
8.8
760
6144
R06AE53
ATC
cyclizine, combinations; systemic
3.6
8.8
28
78
SPAT1312
SPAT
General health counselling
1.3
8.8
959
7989
SFA20
NOMESCO Finland
Two-surface restoration
1.2
8.7
1941
17471
K30
ICD-10 Finland
Functional dyspepsia
1.4
8.7
360
2599
DFF15
NOMESCO Finland
Speech audiometry
1.7
8.7
155
929
SPAT1153
SPAT
Removal of sutures
1.3
8.6
1021
8586
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
8.6
601
4722
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
1.8
8.4
117
652
M01AB05
ATC
diclofenac; systemic, rectal
1.2
8.4
2257
20676
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
8.4
722
5831
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
3.9
8.4
24
62
S83.6
ICD-10 Finland
Sprain and strain of other and unspecified parts of knee
1.7
8.4
164
1007
R52.9
ICD-10 Finland
Pain, unspecified
1.4
8.4
323
2304
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.3
8.3
60
263
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.3
8.3
719
5812
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.4
8.3
312
2215
D01
ICPC
Abdominal pain/cramps general
1.4
8.2
368
2698
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
8.2
947
7934
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.3
8.2
706
5706
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
8.1
430
3237
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
2.5
8.1
50
204
H83.0
ICD-10 Finland
Labyrinthitis
22.1
8.0
11
5
D82
ICPC
Teeth/gum disease
1.2
7.9
1160
9965
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.3
7.9
855
7097
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
7.9
915
7657
SPAT1260
SPAT
Consultation of another employee
1.3
7.9
531
4145
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
7.8
413
3107
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
7.8
562
4432
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.6
7.8
156
966
Z00.0
ICD-10 Finland
General medical examination
1.3
7.7
597
4750
H21.2
ICD-10 Finland
Degeneration of iris and ciliary body
45.1
7.7
9
*
M01AX17
ATC
nimesulide; oral
1.3
7.7
752
6166
WZC00, ,
SPAT
1.3
7.7
461
3540
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.6
7.6
184
1190
R01AD08
ATC
fluticasone; nasal
1.3
7.6
879
7357
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.4
7.5
311
2245
SPAT1283
SPAT
Restricted health certificate
1.4
7.5
412
3121
A02BC03
ATC
lansoprazole; oral
1.2
7.4
903
7593
M48.0
ICD-10 Finland
Spinal stenosis
1.4
7.4
385
2890
R55
ICD-10 Finland
Syncope and collapse
1.4
7.4
331
2426
SPAT1301
SPAT
No procedures
1.2
7.3
955
8093
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
+∞
7.3
7
*
3868X
ICD-9 Finland
Vertiginous syndromes and other disorders of vestibular system, Other disorders of labyrinth
+∞
7.3
7
*
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
+∞
7.3
7
*
J01DA01
ATC
[U] cefalexin
1.2
7.2
2027
18516
H13
ICPC
Plugged feeling ear
1.3
7.2
617
4972
EB1VA, ,
NOMESCO Finland
1.3
7.2
559
4447
R21
ICPC
Throat symptom/complaint
1.3
7.2
570
4547
L17
ICPC
Foot/toe symptom/complaint
1.2
7.2
984
8378
R12
ICD-10 Finland
Heartburn
1.5
7.2
254
1784
P01AB01
ATC
metronidazole; oral, rectal
1.2
7.1
1266
11074
R03BA08
ATC
ciclesonide; inhalant
1.4
7.1
267
1897
G51.0
ICD-10 Finland
Bell palsy
1.9
7.1
83
440
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
7.1
302
2195
N30.9
ICD-10 Finland
Cystitis, unspecified
1.5
7.0
195
1303
H92.0
ICD-10 Finland
Otalgia
1.5
7.0
182
1198
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.0
756
6266
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
7.0
211
1436
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
7.0
834
6996
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
6.9
263
1872
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.6
6.8
160
1029
WW200, ,
SPAT
1.2
6.8
982
8405
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
2.5
6.8
39
155
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.7
590
4769
SFA10
NOMESCO Finland
One-surface restoration
1.2
6.7
1785
16182
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
6.7
353
2655
6266A
ICD-9 Finland
Disorders of menstruation and other abnormal bleeding from female genital tract, Metrorrhagia
1.8
6.7
88
484
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
6.6
216
1493
H01
ICPC
Ear pain/earache
1.4
6.6
331
2472
A05
ICPC
Feeling ill
1.6
6.6
153
984
C10AA07
ATC
rosuvastatin; oral
1.2
6.5
1128
9817
H83.3
ICD-10 Finland
Noise effects on inner ear
3.7
6.5
20
55
Z71.8
ICD-10 Finland
Other specified counselling
1.2
6.5
1061
9188
U02
ICPC
Urinary frequency/urgency
1.3
6.4
452
3551
R75
ICPC
Sinusitis acute/chronic
1.6
6.4
139
880
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
2.8
6.4
31
113
G04CA02
ATC
tamsulosin; oral
1.3
6.4
677
5598
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
2.5
6.3
37
148
M02AA07
ATC
piroxicam; topical
1.2
6.3
1127
9835
G04BD12
ATC
mirabegron; oral
1.3
6.3
381
2927
WZC00
NOMESCO Finland
Treatment plan or consultation
1.2
6.3
1184
10383
N01
ICPC
Headache
1.4
6.3
288
2119
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
6.3
1202
10559
H80.8
ICD-10 Finland
Other otosclerosis
+∞
6.2
6
*
38699, ,
ICD-8 Finland
+∞
6.2
6
*
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.2
1159
10152
M54.3
ICD-10 Finland
Sciatica
1.5
6.2
178
1199
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.2
1684
15255
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.3
6.2
345
2618
L82
ICD-10 Finland
Seborrhoeic keratosis
1.3
6.2
609
4989
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
6.2
626
5147
N89
ICPC
Migraine
1.8
6.2
83
461
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.6
6.1
133
2048
S82
ICPC
Naevus/mole
1.3
6.1
430
3374
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.3
6.1
348
2650
K02.1
ICD-10 Finland
Caries of dentine
1.2
6.1
1900
17407
A04
ICPC
Weakness/tiredness general
1.3
6.1
469
3727
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.3
6.1
392
3040
N06AX11
ATC
mirtazapine; oral
1.2
6.1
1083
9443
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
2.5
6.0
36
146
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1602
10830
1.83
68.34
2.2
2.2
148.47
216.06
u/l
3.53
1540
10255
1847
13156
1.79
65.17
4.0
3.8
38.30
97.06
ng/l
0.99
1308
9383
2535
20387
1.74
53.23
4.8
5.2
6.68
6.73
mmol/l
0.73
2434
19394
2032
16210
1.55
36.96
15.4
15.2
1.23
1.26
inr
1.31
1693
13507
3590
33400
2.51
34.50
21.4
19.8
139.77
139.68
mmol/l
1.41
3550
32809
3595
33474
2.54
34.36
21.5
19.9
3.95
3.98
mmol/l
5.76
3544
32824
3520
32508
2.22
33.94
18.1
16.8
20.71
24.61
mg/l
12.40
2963
26930
811
5407
1.64
31.05
2.0
2.1
29.01
29.67
s
1.89
788
5265
2833
25046
1.52
26.58
5.0
4.5
11.22
12.42
mm/h
5.05
2642
23481
3644
34648
2.47
24.22
24.2
21.9
79.12
77.95
umol/l
1.27
3621
34270
2528
22114
1.43
22.73
5.4
4.8
1415.30
1828.13
e6/l
0.23
56
305
3288
30465
1.61
20.99
6.1
5.5
1.90
1.92
mu/l
0.51
3054
28234
3384
31595
1.68
20.78
17.5
16.4
79.21
79.90
ml/min/173m2
1.22
3213
29394
2911
26340
1.46
20.25
8.8
8.6
77.29
79.59
u/l
1.93
2754
25087
2861
25811
1.45
20.15
4.9
4.5
14.88
14.82
pmol/l
0.65
2634
23796
1389
11150
1.39
19.62
2.8
2.7
62.29
67.91
u/l
0.33
1289
10370
3605
34379
2.07
19.56
13.8
12.6
27.20
26.27
u/l
0.49
3500
33445
3341
31208
1.61
19.07
7.0
6.5
39.26
39.44
mmol/mol
0.68
3122
29258
356
2165
1.71
18.76
1.3
1.3
51.77
52.04
au/ml
0.01
21
159
2064
17728
1.36
18.76
7.0
7.6
1.22
1.21
mmol/l
1.03
1755
15355
380
2361
1.68
18.48
2.5
2.4
20.72
21.79
au/ml
0.08
32
237
2116
18289
1.36
18.22
4.4
4.0
0.02
0.09
estimate
0.43
432
3676
2082
17961
1.35
18.09
4.4
4.0
0.00
0.00
estimate
0.35
442
3838
3665
35291
2.30
17.42
28.2
25.4
246.88
250.72
e9/l
3.26
3626
34613
3665
35296
2.29
17.32
28.0
25.4
91.08
91.28
fl
2.15
3647
34931
3665
35298
2.29
17.29
28.1
25.4
4.50
4.48
e12/l
1.92
3613
34513
3665
35298
2.29
17.29
28.5
25.9
40.56
40.43
%
0.38
3645
34916
3665
35303
2.29
17.19
28.1
25.5
6.68
6.74
e9/l
0.88
3617
34513
3665
35306
2.28
17.14
28.3
25.6
135.74
134.98
g/l
2.70
3647
34953
2094
18172
1.34
17.00
4.4
4.0
2.71
5.00
estimate
0.34
445
3942
2121
18490
1.34
16.44
6.6
6.8
11.04
11.61
umol/l
1.41
2018
17677
3371
31752
1.57
16.27
5.9
5.3
5.96
5.96
mmol/l
0.10
3117
29276
1855
15901
1.33
15.95
6.5
6.9
1.21
1.21
mmol/l
1.01
1714
14735
1242
10112
1.34
14.96
4.6
4.2
0.00
0.00
estimate
0.06
415
3550
3464
32947
1.62
14.74
6.6
5.9
2.68
2.70
mmol/l
0.60
3219
30758
964
7578
1.37
14.54
2.0
1.8
0.89
1.28
mg/l
5.26
728
5910
3404
32280
1.55
14.27
5.7
5.1
1.43
1.47
mmol/l
6.13
3149
30059
3415
32466
1.54
13.49
5.8
5.2
4.60
4.63
mmol/l
1.26
3184
30417
3270
30846
1.45
13.14
4.8
4.4
1.35
1.30
mmol/l
3.24
3010
28434
1592
13605
1.29
12.99
4.4
4.0
0.01
0.24
estimate
0.78
359
3151
848
6821
1.31
10.42
4.2
3.9
377.04
419.41
ng/l
0.15
650
5401
1456
12544
1.26
10.38
3.7
3.4
—
1.53
—
0
5
545
4119
1.38
10.14
5.4
5.0
32.00
32.52
%
0.54
387
2741
385
2749
1.45
9.91
2.9
2.9
10.47
10.68
g/l
0.49
352
2542
73
328
2.25
9.50
1.1
1.1
—
—
—
0
0
1646
14494
1.24
9.36
2.0
1.9
1.44
1.37
mmol/l
1.60
1333
12187
1770
15722
1.24
9.24
2.6
2.5
78.41
78.29
nmol/l
0.06
1593
14280
792
6403
1.30
9.24
1.3
1.3
42.63
30.81
iu/ml
1.06
217
1966
1248
10687
1.25
9.05
3.4
3.2
1218.06
1334.29
ng/l
0.35
1083
9264
955
7929
1.27
9.01
2.8
2.8
5.78
5.57
e6/l
0.15
871
7213
59
249
2.39
8.89
1.1
1.1
226.12
296.79
mg/l
3.03
53
212
736
5944
1.30
8.59
1.3
1.3
13.17
10.80
u/ml
0.39
286
2280
2164
19719
1.23
8.58
9.0
10.0
4.02
4.12
e9/l
1.26
1916
17122
1986
17952
1.22
8.46
6.4
6.6
1.92
1.90
e9/l
0.21
1779
15770
1776
15890
1.22
8.31
5.0
5.3
36.28
35.53
g/l
7.64
1655
14950
59
258
2.31
8.23
1.2
1.1
32.47
43.89
mg/l
2.23
49
212
48
194
2.49
7.97
1.2
1.2
0.53
0.55
ratio
0.15
26
109
1764
15820
1.22
7.92
3.3
3.1
131.79
129.97
ug/l
0.08
1628
14803
659
5307
1.29
7.80
1.5
1.5
—
—
—
0
0
279
1965
1.45
7.73
2.9
3.7
1.48
1.91
mmol/l
1.52
204
1471
2423
22448
1.22
7.73
3.7
3.4
47.80
50.18
u/l
0.63
2273
21074
1085
9282
1.24
7.67
2.7
2.8
344.41
344.13
umol/l
0.03
947
8218
1078
9219
1.24
7.64
2.5
2.4
2.80
2.85
mg/l
0.33
917
7983
1257
10934
1.22
7.56
5.8
5.5
2.46
2.78
ug/l
0.59
1141
9914
1799
16216
1.21
7.51
6.3
6.6
57.16
57.53
%
0.70
1725
15510
1995
18167
1.21
7.46
6.4
6.7
0.19
0.19
e9/l
0.72
1781
15832
917
7730
1.25
7.38
1.3
1.3
1.89
1.67
u/ml
0.13
253
2100
54
239
2.28
7.37
1.0
1.1
—
—
—
0
0
944
7986
1.24
7.35
4.6
4.2
1.02
1.20
kg/l
0.50
617
5369
320
2335
1.40
7.30
3.0
3.9
5.08
5.16
kpa
1.29
299
2253
1341
11777
1.21
7.25
3.4
3.5
36.73
46.70
mg/l
1.42
809
7554
1400
12348
1.21
7.25
3.4
3.5
7.88
7.47
mmol/l
2.67
1153
10462
1782
16112
1.20
7.02
2.8
2.8
—
—
estimate
—
0
0
132
806
1.66
6.96
1.2
1.2
3.66
3.78
mmol/l
0.96
127
763
1357
11973
1.21
6.91
4.1
4.2
6.20
8.71
mg/mmol
1.87
804
7502
1397
12367
1.21
6.85
3.3
3.6
2.36
2.35
mmol/l
1.08
1252
11246
2131
19626
1.20
6.73
3.0
2.8
—
—
—
0
0
385
2935
1.35
6.71
2.4
2.4
5.02
7.61
ug/l
3.51
341
2627
1456
12968
1.20
6.63
4.3
4.0
75.87
101.87
e6/l
0.60
1066
9167
1159
10120
1.21
6.49
1.7
1.7
20.38
20.31
nmol/l
0.06
967
8575
1816
16524
1.19
6.46
6.5
6.7
27.93
27.42
%
1.25
1730
15675
179
1201
1.51
6.36
3.3
4.1
24.84
24.88
mmol/l
0.08
161
1111
126
784
1.63
6.21
1.2
1.3
9.50
33.00
e6/l
1.34
96
574
51
238
2.16
6.18
2.0
2.1
16.60
18.28
nmol/l
0.72
45
223
330
2490
1.36
6.16
1.9
1.9
—
—
—
0
0
498
3987
1.29
6.10
6.9
7.0
—
—
—
0
0
1290
11440
1.19
6.01
3.6
3.4
47.00
82.85
e6/l
1.71
1013
8725
531
4298
1.27
5.96
2.4
2.4
133.96
143.42
ug/g
0.20
415
3459
1101
9635
1.20
5.92
3.8
3.4
0.15
0.21
estimate
0.13
353
3021
126
796
1.60
5.86
1.3
1.4
266.92
1479.48
e6/l
1.99
106
623
1705
15534
1.18
5.70
2.2
2.1
98.23
96.09
pmol/l
1.01
902
8232
212
1505
1.43
5.69
1.9
1.9
37.79
39.41
u/l
0.53
188
1341
421
3334
1.30
5.61
2.4
2.3
358.17
378.86
nmol/l
1.41
382
3109
207
1469
1.43
5.58
1.5
1.7
6.46
6.54
iu/ml
0.01
40
355
353
2740
1.32
5.45
1.9
2.0
—
—
—
0
0
104
641
1.64
5.38
1.3
1.3
288.33
496.79
titre
—
6
56
287
2176
1.35
5.22
1.8
2.0
1.25
1.40
g/l
0.59
262
2011
126
825
1.55
5.08
1.4
1.4
11.00
10.65
u/l
0.09
95
670
999
8780
1.19
4.98
4.9
4.5
21.61
21.77
%
0.13
518
4325
158
1111
1.44
4.53
1.5
1.5
0.41
6.14
iu/ml
0.49
33
208
185
1339
1.40
4.52
1.3
1.2
1.98
1.44
u/ml
0.12
13
98
40
194
2.07
4.49
1.0
1.1
1.24
1.16
u/l
0.10
14
96
1107
9889
1.17
4.45
3.6
3.3
0.39
0.42
e6/l
0.22
833
7265
386
3115
1.27
4.44
2.5
2.9
67.06
66.39
g/l
1.14
350
2879
836
7343
1.18
4.10
1.8
1.7
36283623.74
37707748.90
pmol/l
0.02
678
6150
70
420
1.68
4.10
1.4
1.4
—
—
—
0
0
774
6763
1.18
4.04
1.6
1.5
2.30
2.48
g/l
2.23
480
4201
70
422
1.67
4.03
1.4
1.4
—
—
—
0
0
70
423
1.67
4.00
1.4
1.4
—
—
—
0
0
119
814
1.48
3.98
2.3
2.1
5006.21
5059.59
u/l
0.01
41
317
147
1049
1.42
3.94
1.6
1.6
0.23
0.24
g/l
0.19
137
999
139
982
1.43
3.93
1.2
1.3
3.01
6.06
u/ml
0.43
11
93
33
158
2.10
3.87
1.4
1.3
169.38
166.39
mmol/24h
0.08
33
158
71
438
1.63
3.77
1.4
1.4
—
—
—
0
0
435
3630
1.22
3.72
3.3
3.5
—
—
—
0
0
678
5902
1.18
3.68
1.9
1.7
1215.83
1172.45
nmol/l
0.54
519
4511
71
441
1.62
3.68
1.5
1.4
—
—
—
0
0
149
1082
1.39
3.64
1.6
1.6
1.22
1.19
g/l
0.69
139
1032
26
116
2.25
3.64
1.3
1.3
0.34
0.30
g/l
1.38
18
94
996
8946
1.15
3.61
4.1
4.2
90.15
89.41
%
0.42
984
8754
587
5055
1.19
3.61
6.1
7.4
104.43
104.24
mmol/l
0.47
587
5050
703
6153
1.18
3.57
2.9
3.5
0.82
0.81
mmol/l
0.63
663
5809
71
445
1.61
3.56
1.5
1.4
—
—
—
0
0
564
4850
1.19
3.52
5.2
6.3
1.04
1.04
mmol/l
0.19
511
4519
196
1495
1.33
3.51
1.9
1.5
17.47
17.16
iu/ml
—
7
37
139
1005
1.40
3.49
1.2
1.2
174.38
102.37
titre
0.44
16
97
1645
15307
1.13
3.48
12.1
11.9
0.00
0.00
e9/l
0.64
1382
12502
37
195
1.91
3.38
1.2
1.2
140.69
132.39
nmol/l
0.61
37
195
41
224
1.84
3.36
1.0
1.1
0.09
7.48
nmol/l
—
7
51
349
2878
1.23
3.36
3.2
4.1
1.23
1.23
mmol/l
0.19
303
2495
32
161
2.00
3.34
1.1
1.3
79.60
66.06
%
—
5
18
142
1042
1.38
3.29
1.2
1.2
32.72
43.67
u/ml
0.27
14
52
135
985
1.38
3.24
1.2
1.3
4.09
8.54
u/ml
1.17
20
152
134
980
1.38
3.18
1.9
1.6
294.63
296.43
mu/l
0.02
124
903
69
445
1.56
3.11
1.6
1.5
0.26
0.33
nmol/l
0.73
50
333
65
414
1.58
3.09
1.4
1.4
33.57
28.95
u/l
0.53
50
347
128
934
1.38
3.09
1.8
2.0
10.98
11.98
mg/l
0.82
118
863
691
6114
1.16
3.04
2.7
2.7
14.13
12.98
umol/l
3.72
633
5723
45
263
1.72
2.99
1.2
1.3
1.73
0.98
u/ml
0.33
24
149
600
5264
1.17
2.95
2.8
2.7
23.73
22.60
%
1.30
548
4910
268
2185
1.24
2.90
1.4
1.3
190.69
208.88
u/ml
0.18
255
2023
12
38
3.16
2.84
1.1
1.1
—
—
—
0
0
677
6010
1.15
2.84
2.0
1.9
—
—
—
0
0
1268
11729
1.12
2.81
3.6
3.3
35.87
35.93
u/l
0.00
1194
11085
261
2133
1.24
2.77
3.9
3.6
4.43
4.46
pmol/l
0.14
229
1919
48
294
1.64
2.71
1.0
1.0
284.57
290.61
mg/l
0.25
42
271
643
5706
1.15
2.71
2.7
2.7
2.38
2.31
g/l
2.81
584
5284
49
302
1.63
2.70
1.9
1.6
365.45
320.35
mu/l
0.39
38
247
162
1254
1.30
2.69
1.8
1.8
—
—
—
0
0
68
454
1.51
2.67
1.2
1.3
0.18
0.22
nmol/l
0.56
49
367
150
1151
1.32
2.65
1.6
1.7
—
—
—
0
0
75
512
1.47
2.65
1.2
1.3
0.57
4.09
nmol/l
0.51
69
493
12
41
2.93
2.61
1.0
1.0
—
—
—
0
0
14
55
2.55
2.61
1.6
2.2
—
—
—
0
0
53
337
1.58
2.59
1.1
1.2
—
—
—
0
0
341
2889
1.20
2.55
2.6
2.5
0.19
0.47
e6/l
5.36
321
2766
940
8598
1.12
2.48
2.3
2.5
—
—
—
0
0
110
816
1.36
2.47
1.2
1.2
2.58
5.89
u/ml
—
9
52
36
210
1.72
2.46
1.8
2.7
259.74
222.39
e6/l
0.59
31
185
731
6590
1.14
2.44
3.3
3.3
0.77
0.76
ug/l
0.13
490
4333
173
1370
1.28
2.44
2.0
2.0
—
—
—
0
0
10
32
3.13
2.43
1.0
1.0
—
—
—
0
0
75
523
1.44
2.41
1.3
1.2
8.17
4.10
u/ml
0.57
30
231
104
769
1.36
2.39
1.2
1.2
41.50
46.18
u/ml
0.13
15
84
33
191
1.73
2.33
1.2
1.1
—
—
—
0
0
30
169
1.78
2.32
1.5
1.3
226.33
332.60
u/l
0.73
30
154
69
478
1.45
2.31
1.4
1.3
339.18
303.86
pmol/l
0.31
59
410
21
106
1.99
2.25
1.4
1.2
—
—
—
0
0
201
1639
1.24
2.23
3.6
3.4
25.44
25.30
mmol/l
0.24
194
1581
38
232
1.64
2.23
1.3
1.2
—
—
—
0
0
310
2643
1.19
2.19
1.5
1.7
—
—
—
0
0
205
1679
1.23
2.19
1.1
1.0
—
—
—
0
0
34
203
1.68
2.17
1.1
1.6
5.77
7.19
u/l
0.67
26
179
272
2297
1.20
2.15
3.2
3.1
130.87
128.99
g/l
0.78
266
2232
38
236
1.62
2.10
1.3
1.2
—
—
—
0
0
185
1510
1.24
2.06
1.4
1.4
—
—
—
0
0
93
694
1.35
2.06
4.8
3.4
25.34
27.57
mg/l
0.24
60
469
782
7150
1.12
2.06
3.0
3.1
2.45
2.45
mmol/l
0.80
695
6423
131
1029
1.28
2.02
2.1
1.9
42.70
40.41
nmol/l
0.52
125
992
352
3056
1.17
2.02
3.1
3.1
4.45
4.54
kpa
0.42
346
2967
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
170
1.71
2.00
1.2
1.1
—
—
—
0
0
155
1249
1.25
1.95
2.3
1.9
—
—
—
0
0
678
6168
1.12
1.95
3.4
3.0
1.12
1.08
e6/l
0.10
372
3299
1032
9604
1.10
1.94
3.3
3.0
0.29
0.03
0.83
14
243
108
833
1.31
1.93
1.1
1.1
7.81
5.47
eliau/ml
—
10
103
404
3559
1.15
1.92
3.6
3.8
2.03
1.83
mmol/l
0.59
363
3112
99
755
1.32
1.92
2.1
2.8
16.48
16.26
%
0.35
99
742
71
514
1.39
1.92
1.1
1.1
—
—
—
0
0
121
950
1.28
1.90
1.4
1.4
—
—
—
0
0
477
4256
1.14
1.89
5.1
4.6
239.20
246.73
u/l
0.60
447
4047
326
2835
1.16
1.85
2.6
2.3
13.06
13.28
nmol/l
0.19
284
2570
75
553
1.36
1.83
1.5
1.9
1.61
1.65
mmol/l
0.18
75
538
45
302
1.50
1.82
1.4
1.5
—
—
—
0
0
38
246
1.55
1.81
2.2
2.1
—
—
—
0
0
2785
27146
1.10
1.80
21.6
20.5
13.57
13.68
%
5.02
2761
26779
60
427
1.41
1.80
1.3
1.3
52.95
65.26
u/ml
—
6
21
157
1281
1.24
1.79
1.7
1.6
14.37
17.45
u/ml
0.28
34
283
196
1638
1.21
1.77
4.8
5.5
1.52
1.61
%
0.74
185
1543
181
1501
1.22
1.77
4.9
5.7
0.85
0.88
%
0.54
170
1411
41
272
1.51
1.76
1.0
1.2
—
—
—
0
0
109
854
1.28
1.76
1.2
1.1
3.40
4.20
—
7
105
47
323
1.46
1.71
1.3
1.5
31.93
31.45
%
0.03
23
194
64
466
1.38
1.70
1.4
1.4
—
—
—
0
0
320
2799
1.16
1.70
3.9
4.0
92.68
91.71
ng/l
0.06
266
2416
21
118
1.78
1.70
2.4
2.9
26.86
29.94
umol/l
0.75
14
87
59
424
1.40
1.70
1.6
2.3
29.60
20.88
mg/l
0.45
20
159
366
3235
1.15
1.68
2.8
2.7
69.34
70.55
e9/l
0.26
272
2369
42
284
1.48
1.66
1.0
1.2
—
—
—
0
0
328
2883
1.15
1.64
3.0
2.7
64.62
66.02
ml/min/173m2
0.28
128
1227
207
1754
1.19
1.64
2.2
2.2
0.00
0.46
estimate
0.51
61
557
41
277
1.49
1.63
1.0
1.2
—
—
—
0
0
125
1007
1.25
1.63
4.3
4.3
3.83
3.88
mmol/l
0.72
125
996
148
1215
1.23
1.62
3.9
4.0
1.30
1.39
mmol/l
0.63
148
1197
71
532
1.34
1.60
1.3
1.2
2.95
3.85
u/ml
0.23
22
184
43
295
1.46
1.60
1.0
1.2
—
—
—
0
0
103
813
1.27
1.59
2.3
1.9
209.94
203.09
pmol/l
0.33
94
765
496
4487
1.12
1.59
1.9
1.8
—
—
—
0
0
73
550
1.33
1.59
1.7
1.6
—
—
—
0
0
130
1056
1.24
1.58
1.3
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
143
1174
1.23
1.58
3.3
3.2
0.37
0.35
iu/ml
0.32
83
663
55
397
1.39
1.56
8.8
5.2
7.06
7.31
mmol/l
0.27
48
334
13
247
0.52
1.55
2.6
1.8
—
—
—
0
0
12
57
2.11
1.55
1.8
2.2
—
—
—
0
0
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
52
374
1.40
1.52
1.3
1.2
—
—
—
0
0
182
1538
1.19
1.50
2.4
2.0
—
—
—
0
0
9
185
0.49
1.49
19.6
13.8
551.33
832.04
nmol/l
—
9
178
18
101
1.79
1.48
1.2
1.1
—
—
—
0
0
9
37
2.44
1.47
1.0
1.1
—
—
—
0
0
41
284
1.45
1.47
1.0
1.2
—
—
—
0
0
43
301
1.43
1.46
1.2
1.2
—
—
—
0
0
211
1812
1.17
1.46
1.5
1.5
—
—
—
0
0
33
219
1.51
1.46
1.5
1.3
—
—
—
0
0
172
1452
1.19
1.45
1.5
1.4
28.06
30.21
iu/l
0.38
140
1250
465
4219
1.12
1.43
1.9
1.8
—
—
—
0
0
12
59
2.04
1.43
1.9
1.5
—
0.68
—
0
6
101
808
1.26
1.43
3.3
3.5
113.17
766.26
u/ml
1.26
86
741
258
2255
1.15
1.42
1.3
1.2
101.30
142.64
u/ml
1.25
101
825
58
432
1.35
1.39
1.1
1.1
2.99
2.48
u/ml
0.14
30
214
14
74
1.90
1.39
1.0
1.1
288.38
282.50
pmol/l
—
8
56
110
893
1.24
1.38
1.3
1.3
246.20
218.75
miu/ml
0.34
56
386
541
4962
1.11
1.37
1.5
1.5
—
—
—
0
0
9
41
2.20
1.37
1.1
1.1
—
—
—
0
0
33
223
1.48
1.35
1.5
1.3
—
—
—
0
0
250
2191
1.15
1.34
1.8
1.7
—
—
—
0
0
10
47
2.13
1.33
1.1
1.0
—
—
—
0
0
47
342
1.38
1.31
1.2
1.5
—
—
—
0
0
24
152
1.58
1.31
1.5
1.4
—
—
—
0
0
24
152
1.58
1.31
1.5
1.4
—
—
—
0
0
27
176
1.54
1.31
1.0
1.2
—
—
—
0
0
46
334
1.38
1.30
2.6
2.9
—
—
—
0
0
54
403
1.34
1.30
1.3
1.6
56.24
59.30
%
0.20
25
246
133
1113
1.20
1.26
1.4
1.4
287.97
275.31
ug/g
0.24
72
665
25
162
1.55
1.25
1.0
1.1
—
—
—
0
0
296
2639
1.13
1.25
1.4
1.5
—
—
—
0
0
28
187
1.50
1.23
1.2
1.2
1.09
1.06
ratio
0.75
20
156
9
45
2.00
1.23
3.1
1.9
—
—
—
0
0
51
382
1.34
1.21
1.3
1.2
—
39.80
—
0
5
19
116
1.64
1.21
1.8
2.1
2.11
1.63
ratio
0.86
19
109
81
647
1.26
1.20
1.9
2.0
4.79
4.90
mmol/24h
0.12
73
571
25
164
1.53
1.20
1.2
1.6
—
—
—
0
0
154
1314
1.18
1.19
2.2
2.6
9.84
10.36
g/l
1.02
136
1180
8
38
2.11
1.18
1.7
1.4
—
—
—
0
0
22
141
1.56
1.17
1.4
1.2
—
—
—
0
0
64
500
1.28
1.15
1.1
1.1
1.50
1.51
g/l
0.07
58
452
25
166
1.51
1.14
2.1
2.4
—
—
—
0
0
128
1080
1.19
1.14
2.4
2.5
0.00
0.00
g/l
-0.00
111
948
167
1443
1.16
1.12
2.4
2.5
2.94
2.91
g/l
0.12
151
1319
415
3799
1.10
1.12
4.0
4.3
6.68
22.64
ug/l
3.35
335
3098
27
184
1.47
1.10
1.5
1.9
—
—
—
0
0
27
184
1.47
1.10
1.5
1.9
—
—
—
0
0
27
184
1.47
1.10
1.5
1.9
—
—
—
0
0
27
184
1.47
1.10
1.5
1.9
—
—
—
0
0
176
1530
1.16
1.10
2.3
2.5
3.62
3.72
g/l
0.49
160
1406
176
1531
1.16
1.09
2.3
2.5
4.28
4.24
g/l
0.41
160
1407
176
1531
1.16
1.09
2.3
2.5
7.39
7.37
g/l
0.05
160
1406
25
168
1.49
1.09
1.4
1.8
3.05
3.30
u/field
0.06
20
122
28
193
1.45
1.09
2.1
1.6
14.55
9.50
ug/l
0.54
22
167
114
957
1.20
1.08
1.4
1.3
—
—
—
0
0
53
408
1.30
1.07
1.4
1.3
282.87
277.10
mosm/kgh2o
0.93
39
315
374
3416
1.11
1.06
2.8
2.5
38.09
54.05
u/l
0.55
313
2902
91
749
1.22
1.06
6.6
7.9
104.66
105.20
mmol/l
0.41
80
664
363
3311
1.11
1.06
6.5
7.8
1.34
1.34
mmol/l
0.05
357
3251
107
897
1.20
1.04
1.7
1.6
13165.77
12206.39
e6/l
0.08
71
626
37
271
1.37
1.04
1.2
1.2
44.00
127.88
titre
—
5
52
69
553
1.25
1.03
1.2
1.1
26.41
20.32
au/ml
0.15
12
133
27
187
1.45
1.03
3.1
2.3
102.81
98.38
%
0.29
27
178
13
75
1.74
1.02
7.4
7.5
7.30
5.47
kpa
0.45
13
75
10
53
1.89
1.01
1.0
1.2
—
—
—
0
0
39
518
0.75
1.01
1.4
1.6
60.69
60.90
ug/l
0.01
30
429
29
205
1.42
1.00
1.9
2.6
383.87
558.51
e6/l
1.59
24
172
7
35
2.00
1.00
1.0
1.0
0.10
5.42
u/ml
—
7
35
38
283
1.35
0.98
2.3
1.9
18.86
7.58
umol/l
0.57
27
211
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
102
858
1.19
0.97
2.0
2.4
129.57
128.74
g/l
0.13
82
671
130
1117
1.17
0.97
2.4
2.5
0.01
0.02
g/l
0.69
118
1005
15
92
1.63
0.97
1.1
1.2
—
—
—
0
0
0
31
0.00
0.96
0.0
1.3
—
21.16
—
0
31
20
133
1.51
0.94
1.3
2.2
—
22089.96
—
0
23
145
1261
1.16
0.94
3.4
3.7
37.52
97.51
mg/l
0.79
123
1078
6
27
2.22
0.93
1.2
1.3
0.83
0.91
ml/s/173m2
—
6
21
445
4130
1.09
0.92
3.0
2.8
8.24
8.19
umol/l
0.01
381
3649
141
1227
1.15
0.91
2.7
2.7
—
—
—
0
0
26
184
1.42
0.91
1.4
1.2
—
—
—
0
0
253
2287
1.11
0.91
7.6
7.2
24.64
24.49
mmol/l
0.28
244
2187
22
151
1.46
0.90
1.2
1.3
—
—
—
0
0
144
1259
1.15
0.88
3.4
3.7
27.52
65.00
mg/l
2.28
122
1076
16
103
1.56
0.87
1.0
1.1
—
—
—
0
0
2755
27114
1.06
0.86
23.6
21.4
332.99
332.07
g/l
6.40
2749
26964
29
212
1.37
0.86
2.2
2.8
39.72
41.67
%
0.28
18
111
269
2450
1.11
0.85
8.4
10.0
93.52
93.81
%
0.27
269
2443
31
230
1.35
0.84
1.6
1.5
86.71
84.10
umol/l
0.07
31
230
81
679
1.20
0.83
1.2
1.3
—
—
—
0
0
81
679
1.20
0.83
1.2
1.3
—
—
—
0
0
48
380
1.27
0.83
1.5
1.7
—
—
—
0
0
19
129
1.48
0.83
1.3
1.9
—
—
—
0
0
10
166
0.60
0.83
14.7
13.0
0.57
0.63
mmol/l
—
10
153
386
3582
1.09
0.82
7.8
8.9
122.08
121.37
g/l
0.30
376
3496
63
516
1.22
0.82
6.0
6.5
11.70
12.11
mg/l
0.35
58
485
85
718
1.19
0.81
3.7
3.2
7.14
7.52
mmol/l
1.08
85
696
35
267
1.31
0.80
3.1
2.7
25.11
30.68
mg/l
0.52
27
189
90
765
1.18
0.80
1.5
1.6
—
—
—
0
0
42
329
1.28
0.80
1.5
1.6
—
—
—
0
0
42
329
1.28
0.80
1.5
1.6
—
—
—
0
0
42
329
1.28
0.80
1.5
1.6
—
—
—
0
0
19
271
0.70
0.80
1.3
1.3
—
—
—
0
0
16
106
1.51
0.78
1.1
1.1
—
—
—
0
0
8
48
1.67
0.78
1.0
1.1
—
—
—
0
0
24
173
1.39
0.78
4.0
4.2
—
—
—
0
0
13
82
1.59
0.78
1.0
1.1
—
—
—
0
0
21
148
1.42
0.77
1.7
2.4
230.27
143.93
umol/l
0.43
11
86
101
871
1.16
0.77
3.5
3.1
1.48
1.59
mmol/l
0.57
101
846
128
1124
1.14
0.76
3.3
3.5
1.47
2.98
ratio
2.11
68
650
10
59
1.70
0.75
6.5
7.5
10.04
10.50
%
—
10
59
35
271
1.29
0.74
2.2
2.1
1.96
1.51
u/field
0.19
23
148
9
55
1.64
0.73
1.6
1.4
3.03
578267.16
nmol/l
—
9
46
5
25
2.00
0.72
1.2
1.0
—
—
—
0
0
22
299
0.73
0.71
1.4
1.6
—
—
—
0
0
106
924
1.15
0.71
1.1
1.1
—
—
—
0
0
93
803
1.16
0.71
2.7
2.3
83.17
104.40
ug/min
0.21
47
486
23
168
1.37
0.71
1.1
1.1
1544.48
1536.20
miu/ml
0.02
23
168
5
26
1.92
0.70
1.4
1.1
—
—
—
0
0
120
1058
1.14
0.69
1.7
1.8
—
30.85
—
0
5
39
310
1.26
0.69
1.1
1.2
—
65.88
—
0
8
19
135
1.41
0.69
1.7
2.1
—
—
—
0
0
19
135
1.41
0.69
1.7
2.1
—
—
—
0
0
19
135
1.41
0.69
1.7
2.1
—
—
—
0
0
148
1324
1.12
0.68
2.8
2.6
1.00
1.07
g/l
0.08
128
1140
11
69
1.60
0.68
1.0
1.1
0.69
0.73
umol/24h
—
6
36
409
3840
1.07
0.68
7.4
8.4
95.52
95.53
%
0.01
395
3711
49
401
1.22
0.68
1.1
1.1
5.44
3.80
u/ml
0.26
21
176
7
43
1.63
0.66
2.3
1.4
—
—
—
0
0
16
226
0.71
0.66
1.1
1.1
51.37
16.81
u/ml
—
7
96
13
86
1.51
0.66
1.0
1.1
—
—
—
0
0
20
145
1.38
0.65
8.9
5.4
79.67
61.79
mg/l
0.61
12
103
63
744
0.84
0.65
1.8
2.0
0.97
0.87
nmol/l
0.74
53
632
120
1064
1.13
0.65
3.1
3.1
1.49
1.59
mg/l
0.75
108
972
32
405
0.79
0.64
1.4
1.4
32214.70
81829.08
e6/l
1.30
20
238
49
404
1.22
0.64
1.5
1.7
—
—
—
0
0
41
503
0.81
0.63
1.2
1.6
—
—
—
0
0
41
332
1.24
0.63
1.2
1.4
344800.13
86541.68
e6/l
0.69
30
232
14
96
1.46
0.61
1.1
1.1
—
—
—
0
0
105
928
1.14
0.61
1.1
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
22.30
—
0
9
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
0
21
0.00
0.60
0.0
1.0
—
5.04
—
0
16
454
4300
1.06
0.60
7.2
8.1
12.09
12.28
kpa
0.37
437
4140
301
2811
1.08
0.59
3.1
3.0
223.14
192.74
ng/l
0.37
279
2574
454
4301
1.06
0.59
7.2
8.1
5.07
5.10
kpa
0.39
437
4141
77
884
0.87
0.58
1.6
1.6
—
—
—
0
0
13
89
1.46
0.58
1.0
1.1
6.30
10.84
u/ml
—
8
61
52
438
1.19
0.57
1.5
2.4
0.13
0.49
mmol/l
0.27
52
423
84
736
1.14
0.57
3.5
6.0
440.42
499.38
iu/ml
0.09
12
108
40
484
0.82
0.56
1.4
1.5
0.97
0.96
ratio
0.08
24
301
40
484
0.82
0.56
1.4
1.5
1.21
1.15
ratio
0.15
24
301
40
484
0.82
0.56
1.4
1.5
1.67
1.17
ratio
1.08
24
303
20
150
1.34
0.55
1.2
1.2
7.55
10.00
mm/h
0.82
20
150
6
37
1.62
0.55
1.0
1.2
1.41
1.80
umol/24h
—
6
37
82
719
1.14
0.55
1.2
1.4
—
—
—
0
0
68
588
1.16
0.55
1.2
1.3
—
—
—
0
0
114
1023
1.12
0.54
1.3
1.3
—
—
—
0
0
14
99
1.42
0.54
1.3
1.7
—
—
—
0
0
69
599
1.15
0.54
1.2
1.4
—
—
—
0
0
28
222
1.26
0.53
1.4
1.5
7.37
6.93
u/l
0.06
23
185
33
268
1.23
0.52
1.4
1.5
17.17
19.09
u/ml
—
6
44
359
3394
1.06
0.52
7.2
7.7
9.65
10.11
mmol/l
0.58
334
3261
40
479
0.83
0.52
1.4
1.5
—
—
—
0
0
107
960
1.12
0.52
1.6
2.0
3.17
9.86
iu/l
0.60
41
399
95
847
1.12
0.51
1.2
1.4
—
—
—
0
0
44
371
1.19
0.49
1.1
1.1
0.49
0.27
u/ml
0.25
16
129
58
668
0.87
0.48
1.2
1.3
20.95
36.84
u/l
1.66
49
575
10
68
1.47
0.47
1.3
1.2
—
—
—
0
0
447
4271
1.05
0.46
7.2
8.0
1.17
0.97
mmol/l
0.51
375
3510
15
111
1.35
0.46
1.1
1.1
—
—
—
0
0
21
164
1.28
0.46
1.3
1.2
—
—
—
0
0
7
49
1.43
0.46
9.9
11.4
4.39
5.48
mmol/l
—
7
49
45
384
1.17
0.45
4.1
3.8
60.30
57.47
%
0.42
38
330
82
732
1.12
0.45
3.1
3.4
0.84
0.80
nmol/l
0.36
68
587
105
952
1.11
0.44
2.7
3.5
1.44
1.97
index
0.58
57
483
68
602
1.13
0.43
1.5
1.4
172.86
151.59
au/ml
0.64
14
177
17
131
1.30
0.42
1.1
1.0
—
—
—
0
0
6
95
0.63
0.42
2.8
1.8
92.10
66.54
u/l
—
6
90
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
4.7
—
—
—
0
0
50
435
1.15
0.41
1.5
1.9
89.82
89.61
%
0.12
50
429
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
27
222
1.22
0.41
1.9
2.0
8.03
8.59
mmol/l
0.33
27
222
11
79
1.39
0.40
1.2
1.1
—
—
—
0
0
16
123
1.30
0.40
2.2
1.9
0.95
1.03
u/ml
—
5
33
23
186
1.24
0.40
1.0
2.5
3017.30
1037.49
u/ml
0.36
23
186
8
60
1.33
0.40
1.0
1.5
—
10225.00
—
0
6
71
793
0.89
0.40
1.2
1.5
—
—
—
0
0
115
1055
1.09
0.40
1.8
1.8
—
—
—
0
0
56
493
1.14
0.39
1.1
1.1
2.07
1.39
u/ml
0.19
31
254
36
306
1.18
0.39
1.6
1.5
50.62
56.98
ug/l
0.61
36
306
13
97
1.34
0.39
1.2
1.0
—
—
—
0
0
30
356
0.84
0.38
4.9
3.9
—
—
—
0
0
86
947
0.91
0.38
1.5
1.5
—
—
—
0
0
9
68
1.32
0.37
1.4
1.6
—
—
—
0
0
89
810
1.10
0.37
2.1
2.5
62.35
62.04
%
0.04
89
805
16
125
1.28
0.37
1.1
1.1
—
—
—
0
0
375
3599
1.05
0.35
2.2
2.3
0.21
0.21
g/l
0.31
348
3372
13
99
1.31
0.35
1.2
1.1
—
—
—
0
0
26
217
1.20
0.35
1.5
2.5
0.57
0.70
e9/l
1.09
26
210
22
266
0.83
0.35
3.0
2.2
682.69
635.89
ml
0.23
16
174
48
424
1.13
0.34
1.1
1.1
2.51
2.84
eliau/ml
0.12
19
185
180
1697
1.06
0.33
1.7
1.8
1.48
1.54
g/l
0.36
156
1462
14
109
1.29
0.33
2.1
2.8
9.79
10.21
kpa
0.26
14
109
14
109
1.29
0.33
2.1
2.8
4.75
4.90
kpa
0.35
14
109
12
155
0.77
0.33
4.0
1.6
40.30
40.16
g/l
0.06
12
155
13
166
0.78
0.33
1.7
2.1
115.60
181.61
ug/min
—
5
38
71
644
1.10
0.33
1.2
1.2
256.84
276.98
u/ml
0.26
48
389
43
378
1.14
0.33
2.0
1.8
—
—
—
0
0
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
99
1071
0.92
0.32
1.1
1.1
0.60
0.63
ratio
0.15
11
154
108
1001
1.08
0.32
2.7
2.3
196.17
193.45
%
0.09
101
956
10
132
0.76
0.32
1.8
2.1
23.80
19.92
ug/l
—
10
119
139
1302
1.07
0.31
2.2
2.2
351.59
657.43
ug/l
0.93
132
1237
578
5614
1.03
0.31
3.5
3.1
2.47
2.54
e6/l
0.06
274
2738
120
1121
1.07
0.30
1.5
1.3
—
—
—
0
0
10
75
1.33
0.30
6.3
7.9
60.40
70.92
%
—
10
61
25
212
1.18
0.30
1.8
1.8
95.66
119.74
ng/l
0.89
25
212
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
13
102
1.28
0.30
1.5
1.2
97.62
101.97
%
0.19
13
95
69
630
1.10
0.29
1.2
1.1
2.86
2.08
u/ml
0.20
39
347
26
302
0.86
0.28
1.2
1.6
—
—
—
0
0
35
308
1.14
0.27
1.0
1.1
—
—
—
0
0
86
798
1.08
0.26
2.8
2.8
32.20
35.50
umol/l
0.71
80
715
9
72
1.25
0.25
1.3
1.5
—
—
—
0
0
9
74
1.22
0.25
5.6
2.4
3.67
51.86
ug/l
—
9
74
9
77
1.17
0.24
1.1
1.3
—
—
—
0
0
6
82
0.73
0.24
1.2
1.3
—
—
—
0
0
53
577
0.92
0.22
1.6
1.4
—
—
—
0
0
53
577
0.92
0.22
1.1
1.1
41.17
1112.75
iu/ml
0.52
12
120
11
88
1.25
0.22
1.1
1.2
—
—
—
0
0
5
40
1.25
0.22
1.4
1.1
—
—
—
0
0
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
18
153
1.18
0.22
2.6
3.3
0.69
1.16
%
1.36
18
153
5
42
1.19
0.21
1.4
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
1.68
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
1.38
—
0
13
0
13
0.00
0.21
0.0
1.1
—
13.72
—
0
8
0
13
0.00
0.21
0.0
6.4
—
392.38
—
0
13
0
14
0.00
0.20
0.0
1.2
—
2.71
—
0
14
12
144
0.83
0.19
3.6
2.7
0.65
0.61
mmol/l
0.92
12
144
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
19
218
0.87
0.19
1.4
1.4
—
—
—
0
0
32
289
1.11
0.19
1.2
1.4
1.62
1.16
promille
0.92
25
225
31
343
0.90
0.19
1.2
1.4
—
—
—
0
0
64
599
1.07
0.18
4.3
3.7
1.46
1.57
%
0.11
57
538
42
456
0.92
0.18
1.4
1.4
3642.58
3564.93
e6/l
0.01
31
332
42
456
0.92
0.18
1.0
1.1
—
—
—
0
0
7
59
1.19
0.18
2.0
1.5
0.60
0.48
e9/l
—
7
59
26
233
1.12
0.17
1.2
1.5
—
—
—
0
0
11
91
1.21
0.17
1.1
3.1
1.98
1.85
ratio
0.14
11
86
217
2103
1.03
0.17
8.7
10.9
16.24
15.96
%
0.87
207
2027
11
131
0.84
0.17
1.0
1.3
—
—
—
0
0
12
101
1.19
0.16
1.1
1.4
72.17
87.21
%
—
6
56
14
120
1.17
0.16
1.1
1.5
61.43
363.55
nmol/24h
0.70
14
120
95
906
1.05
0.16
1.4
1.2
—
—
—
0
0
101
965
1.05
0.16
1.3
1.6
—
—
—
0
0
12
102
1.18
0.15
1.1
1.2
76.17
88.16
%
—
6
56
30
275
1.09
0.14
1.0
1.0
260.89
322.84
ng/l
0.84
18
187
30
275
1.09
0.14
1.0
1.0
773.29
733.63
ng/l
0.15
17
183
118
1137
1.04
0.13
1.7
1.7
3.29
4.88
mg/l
1.28
95
850
8
99
0.81
0.13
1.9
1.5
—
—
—
0
0
169
1741
0.97
0.13
4.3
3.4
1.02
1.02
ratio
0.23
152
1561
28
257
1.09
0.13
1.1
1.2
—
—
—
0
0
30
277
1.08
0.12
1.0
1.0
39.72
43.86
ng/l
0.19
18
185
34
316
1.08
0.12
8.1
5.6
203.86
73.27
u/ml
0.38
14
95
154
1497
1.03
0.12
2.2
2.0
2.14
2.21
ug/l
0.03
129
1340
14
157
0.89
0.11
1.0
1.1
—
—
—
0
0
12
105
1.14
0.11
1.5
1.5
8.07
9.05
ug/l
0.23
12
105
22
239
0.92
0.10
1.1
1.2
—
—
—
0
0
48
456
1.05
0.10
1.6
1.9
20.52
26.85
ug/l
0.65
48
449
342
3371
1.02
0.09
1.9
2.0
3.53
3.46
ratio
0.46
264
2635
27
253
1.07
0.08
1.1
1.5
—
—
—
0
0
8
75
1.07
0.07
1.3
1.2
—
—
—
0
0
18
194
0.93
0.07
1.0
1.6
—
—
—
0
0
18
194
0.93
0.07
1.0
1.6
—
—
—
0
0
76
738
1.03
0.07
1.3
1.4
—
—
—
0
0
53
513
1.03
0.06
1.1
1.1
1.17
1.27
u/ml
0.07
27
219
14
129
1.09
0.05
1.0
1.5
—
—
—
0
0
20
212
0.94
0.05
1.3
1.7
—
—
—
0
0
388
3909
0.99
0.04
1.7
1.8
1.37
1.49
%
4.01
341
3440
107
1052
1.02
0.04
2.7
2.4
3.37
3.59
g/l
0.99
101
1001
22
209
1.05
0.04
11.4
7.2
8.86
174.99
ug/l
0.90
15
132
46
473
0.97
0.04
1.2
1.6
—
—
—
0
0
28
291
0.96
0.04
1.2
1.2
119.86
108.72
pmol/l
0.61
28
291
101
995
1.02
0.03
1.4
1.6
—
—
—
0
0
33
341
0.97
0.03
2.3
3.5
9.24
12.50
index
2.87
17
188
54
528
1.02
0.03
1.1
1.1
4.83
3.51
u/ml
0.35
25
275
15
159
0.94
0.03
1.0
1.1
—
—
—
0
0
44
429
1.03
0.03
1.6
1.6
—
—
—
0
0
87
882
0.99
0.02
1.6
1.6
1017.74
1018.44
mu/l
0.00
69
721
39
399
0.98
0.02
1.2
1.4
1.39
1.50
nmol/l
0.24
32
364
247
2457
1.01
0.02
1.6
1.8
3.33
3.46
mmol/l
0.93
175
1722
12
113
1.06
0.01
1.3
1.5
3.33
3.29
mmol/l
0.01
12
103
23
223
1.03
0.01
1.4
1.4
1.24
1.18
nmol/l
0.11
14
163
68
688
0.99
0.01
1.5
1.7
—
—
—
0
0
23
236
0.97
0.00
1.3
1.4
140.56
197.98
pmol/l
0.72
23
236
23
225
1.02
0.00
1.2
1.5
—
—
—
0
0
27
265
1.02
0.00
3.0
1.6
4.22
4.66
ug/l
0.12
22
221
47
465
1.01
0.00
1.1
1.1
—
—
—
0
0
144
1435
1.00
0.00
1.6
1.7
0.36
0.32
mg/l
0.27
53
682
15
149
1.01
0.00
21.3
29.2
119.60
115.18
ug/l
—
10
122
111
1111
1.00
0.00
1.5
1.4
—
—
—
0
0
138
1381
1.00
0.00
3.6
3.5
585.91
3736.65
u/ml
0.87
121
1187
0
5
0.00
0.00
0.0
8.4
—
74.80
—
0
5
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
1.44
—
0
8
6
61
0.98
-0.00
1.7
2.2
19.73
16.99
umol/l
—
6
61
0
8
0.00
-0.00
0.0
1.0
—
305.50
—
0
8
5
54
0.93
-0.00
1.2
1.2
33.92
43.72
mg/l
—
5
48
7
78
0.90
-0.00
1.6
1.3
1.19
1.18
mmol/l
—
7
78
5
54
0.93
-0.00
1.2
1.5
165.40
135.65
ug/l
—
5
48
5
58
0.86
-0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_VESTIBNEUR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VESTIBNEUR | 0.785 [0.71, 0.87] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.546 |
During the follow-up period (1.1.1998 — 31.12.2019), 927 out of 9696 females with H8_VESTIBNEUR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_VESTIBNEUR | 0.686 [0.61, 0.77] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.009 |
During the follow-up period (1.1.1998 — 31.12.2019), 874 out of 8342 males with H8_VESTIBNEUR died.
Mortality risk
Mortality risk for people of age
years, who have H8_VESTIBNEUR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.077% | 0.117% |
| 5 | 0.463% | 0.769% |
| 10 | 1.285% | 1.988% |
| 15 | 2.53% | 3.927% |
| 20 | 4.332% | 6.882% |
Relationships between endpoints
↥Index endpoint: H8_VESTIBNEUR – Vestibular neuronitis
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data